Which statement about CVADs best describes their use?

Which statement about CVADs best describes their use?

• A. Frequent, continuous, rapid, or intermittent administration of fluids and drugs.
• B. Only for vesicant drugs.
• C. Not used for blood products or parenteral nutrition.
• D. They are used exclusively for short-term vascular access.

Answer: (A)

Central venous access devices are designed to provide reliable venous access for ongoing therapy, including frequent, rapid, or intermittent delivery of fluids and drugs over extended periods. This capability makes them ideal for patients who need repeated infusions, large volumes, or complex treatments like parenteral nutrition and blood products, while minimizing repeated needle sticks. That’s why the statement describing frequent, continuous, rapid, or intermittent administration best captures their use. The other notions don’t fit: CVADs aren’t limited to vesicant drugs; they’re commonly used for blood products and parenteral nutrition; and they’re not restricted to short-term access—many CVADs serve long-term and ongoing therapy as well.

Central venous access devices are designed to provide reliable venous access for ongoing therapy, including frequent, rapid, or intermittent delivery of fluids and drugs over extended periods. This capability makes them ideal for patients who need repeated infusions, large volumes, or complex treatments like parenteral nutrition and blood products, while minimizing repeated needle sticks. That’s why the statement describing frequent, continuous, rapid, or intermittent administration best captures their use. The other notions don’t fit: CVADs aren’t limited to vesicant drugs; they’re commonly used for blood products and parenteral nutrition; and they’re not restricted to short-term access—many CVADs serve long-term and ongoing therapy as well.